Evanston Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-68,193
| Closed | -$7.72M | – | 78 |
|
|
2018
Q2 | $7.72M | Buy |
68,193
+6,984
| +11% | +$790K | 1.74% | 32 |
|
|
2018
Q1 | $6.88M | Buy |
61,209
+2,010
| +3% | +$226K | 1.6% | 35 |
|
|
2017
Q4 | $8.76M | Buy |
59,199
+2,875
| +5% | +$425K | 2.1% | 16 |
|
|
2017
Q3 | $6.6M | Buy |
56,324
+1,041
| +2% | +$122K | 1.59% | 35 |
|
|
2017
Q2 | $7.17M | Buy |
55,283
+8,426
| +18% | +$1.09M | 1.76% | 31 |
|
|
2017
Q1 | $6.34M | Sell |
46,857
-4,381
| -9% | -$593K | 1.72% | 36 |
|
|
2016
Q4 | $7.35M | Sell |
51,238
-682
| -1% | -$97.8K | 2.26% | 15 |
|
|
2016
Q3 | $6.13M | Buy |
51,920
+1,882
| +4% | +$222K | 1.92% | 27 |
|
|
2016
Q2 | $5.3M | Buy |
50,038
+4,880
| +11% | +$517K | 1.73% | 31 |
|
|
2016
Q1 | $5.03M | Buy |
+45,158
| New | +$5.03M | 1.66% | 36 |
|
|
2015
Q2 | – | Sell |
-39,619
| Closed | -$6.83M | – | 66 |
|
|
2015
Q1 | $6.83M | Sell |
39,619
-2,354
| -6% | -$406K | 2.24% | 7 |
|
|
2014
Q4 | $5.44M | Buy |
41,973
+121
| +0.3% | +$15.7K | 1.92% | 30 |
|
|
2014
Q3 | $5.38M | Sell |
41,852
-14,886
| -26% | -$1.91M | 1.82% | 28 |
|
|
2014
Q2 | $5.02M | Buy |
+56,738
| New | +$5.02M | 1.74% | 34 |
|